Schouwenburg, M.G.; Suijkerbuijk, K.P.M.; Koornstra, R.H.T.; Jochems, A.; van Zeijl, M.C.T.; van den Eertwegh, A.J.M.; Haanen, J.B.A.G.; Aarts, M.J.B.; van Akkooi, A.C.J.; van den Berkmortel, F.W.P.J.;
et al. Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH? Cancers 2019, 11, 1940.
https://doi.org/10.3390/cancers11121940
AMA Style
Schouwenburg MG, Suijkerbuijk KPM, Koornstra RHT, Jochems A, van Zeijl MCT, van den Eertwegh AJM, Haanen JBAG, Aarts MJB, van Akkooi ACJ, van den Berkmortel FWPJ,
et al. Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH? Cancers. 2019; 11(12):1940.
https://doi.org/10.3390/cancers11121940
Chicago/Turabian Style
Schouwenburg, Maartje G., Karijn P.M. Suijkerbuijk, Rutger H.T. Koornstra, Anouk Jochems, Michiel C.T. van Zeijl, Alfons J.M. van den Eertwegh, John B.A.G. Haanen, Maureen J.B. Aarts, Alexander C.J. van Akkooi, Franchette W.P.J. van den Berkmortel,
and et al. 2019. "Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?" Cancers 11, no. 12: 1940.
https://doi.org/10.3390/cancers11121940
APA Style
Schouwenburg, M. G., Suijkerbuijk, K. P. M., Koornstra, R. H. T., Jochems, A., van Zeijl, M. C. T., van den Eertwegh, A. J. M., Haanen, J. B. A. G., Aarts, M. J. B., van Akkooi, A. C. J., van den Berkmortel, F. W. P. J., de Groot, J. W. B., Hospers, G. A. P., Kapiteijn, E., Kruit, W. H., Piersma, D., van Rijn, R. S., ten Tije, A. J., Vreugdenhil, G., van der Hoeven, J. J. M.,
& Wouters, M. W. J. M.
(2019). Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH? Cancers, 11(12), 1940.
https://doi.org/10.3390/cancers11121940
